← All organizations

Gruppo Oncologico Italiano di Ricerca Clinica

Academic/HospitalWebsite ↗

Also known as: GOIRC - Gruppo Oncologico Italiano di Ricerca Clinica | Gruppo Oncologico Italiano di Ricerca Clinica

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 30, 2024

Timeline

2010s

Apr 1, 2015
Gruppo Oncologico Italiano di Ricerca Clinica— Founded

Drugs by trial phase (24 distinct, 23 trials)

Phase 4 (1 own, 0 via acquisition)

edoxaban

Phase 3 (11 own, 0 via acquisition)

Phase 2 (12 own, 0 via acquisition)

Indications

Studied for

Recent trials (31)

NCT06663098Lead sponsorPhase 2Oct 30, 2024
NCT06464068Lead sponsorPhase 2Jan 16, 2024
NCT06418087OfficialPhase 2May 27, 2022
NCT06418087Lead sponsorPhase 2May 27, 2022
NCT04996017Lead sponsorPhase 3Sep 1, 2021
NCT05015010Lead sponsorPhase 2May 20, 2021
NCT04730999Lead sponsorPhase 2Jul 1, 2020
NCT04072198Lead sponsorPhase 2Sep 30, 2019
NCT04072198Overall official - principal investigatorPhase 2Sep 30, 2019
NCT03976518Lead sponsorPhase 2Jul 1, 2019
NCT04072068Lead sponsorPhase 4Jun 27, 2019
NCT04072068Overall official - principal investigatorPhase 4Jun 27, 2019
NCT03627728Lead sponsorPhase 2Jun 13, 2018
NCT03542461Lead sponsorPhase 3Sep 25, 2017
NCT03469713Lead sponsorPhase 2Jul 14, 2017

Details

Founded: Milan, IT Apr 1, 2015
Last known activity: Oct 30, 2024